N-RAS oncogene mutations in patients with agnogenic myeloid metaplasia in leukemic transformation

Leukemia Research

Volumn 22, Issue 7, 1998, Pages 639-643

  Wang, Jen C ^a   Chen, Chi ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Agnogenic myeloid metaplasia; Leukemic transformation; N RAS gene

Indexed keywords

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CELL TRANSFORMATION; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MALE; MYELOID METAPLASIA; ONCOGENE N RAS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, RAS; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; MUTATION; MYELOID METAPLASIA;

EID: 0031818807     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00059-9     Document Type: Article

References (26)

1. Ward H.P., Block M.H. The natural history of agnogenic mveloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine. 50:1971;357.
2. Hasselbach H. Idiopathic myelofibrosis: a clinical study of 80 patients. Am J Hematol. 34:1990;291.
3. Rosenthal D.S., Moloney W.C. Myeloid metaplasia: a study of 98 cases. Postgrad Med J. 45:1969;136.
4. Silverstein M.N., Brown A.L., Linman J.W. Idiopathic myeloid metaplasia: its evolution into acute leukemia. Arch Intern Med. 132:1973;709.
5. Brandt L., Mitelman F., Panani A. Cytogenic differences between bone marrow in a case of agnogenic myeloid metaplasia developing blast crisis. Scand J Haematol. 15:1975;187.
6. McCarthy D.M. Myelofibrosis: prognostic factors and treatment. Br J Haematol. 69:1988;295.
7. Farr C.J., Saiki R.K., Erlich H.A., McCormick F., Marshall C.J. Analysis of RAS gene mutations in acute myeloid leukemia by polyrnerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA. 85:1988;1629.
8. Bos J.L. The RAS gene family in human carcinogenesis. Mutat Res. 195:1988;225.
9. Browett P.J., Norton J.D. Analysis of RAS gene mutations and methylation state in human leukemias. Oncogene. 4:1989;1029.
10. Paquette R.L., Landaw E.M., Pierre R.V., Kahan J., Lubbert M., Lazcano O., Isaac G., McCormick F., Koeffler H.P. N-RAS mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. Blood. 82:1993;590.
11. Gaidano G., Guerrasio A., Serra A., Rege-Carnbrin G., Salgio G. Molecular mechanisms of tumor progression in chronic myeloproliferative disorders. Leukemia. 8(Suppl. 1):1994;S27.
12. Gaidano G., Guerrmsio A., Serra A., Carozzi F., Rege-Cambrin G., Petroni D., Salgio G. Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders. Leukemia. 7:1993;946.
13. Pagliuca A., Layton D.M., Manoharan A., Gordon S., Green P.J., Mufti G.J. Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. Br J Haematol. 71:1989;499.
14. Hernandez J.M., San Miguel J.F., Gonzalez M., Orfao A., McCanizo M.C., Bascones C., Hernandez J., Lopez-Borrasca A. Development of acute leukaemia after idiopathic myelofibrosis. Arch Pathol. 45:1992;427.
15. Erber W.N., Brenton-Gorius J., Villeval J.L., Oscier D.G., Bai Y., Mason D.Y. Detection of cells of megakaryocyte lineage in haematological malignancies by immuno-alkaline phosphatase labeling cell smears with a panel of monoclonal antibodies. Br J Haematol. 65:1987;87.
16. Bashey A., Gill R., Levi S., Farr C.J., Clutterbuck R., Millar J.L., Pragnell I.B., Marshall C.J. Mutational activation of the N-RAS oncogene assessed in primary clonogenic culture of acute myeloid leukemia (AML): implications for the role of N-RAS mutation in AML pathogenesis. Blood. 74:1992;981.
17. Farr C.J., Saiki R.K., Erlich H.A., McCormick F., Marshall C.J. Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA. 85:1988;1629.
18. Suzuki Y., Orita M., Shiraishi M., Hayashi K., Keklya T. Detection of RAS gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene. 5:1990;1037.
19. Janssen J.W.G., Steenvoorden A.C.M., Lyons J., Anger B., Bohlke J.U., Bos J.L., Seliger H., Bartram C.R. Ras gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl Acad Sci USA. 84:1987;9228.
20. Buschle M., Janssen J.W.G., Drexler H., Lyons J., Anger B., Bartram C.R. Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterized by a N-RAS gene mutation. Leukemia. 2:1988;658.
21. Reilly J.T., Wilson G., Barnett D., Watmore A., Potter A. Karyotypic and RAS gene mutational analysis in idiopathic myelofibrosis. Br J Haematol. 88:1994;575.
22. Vogelstein B., Kinzler K.W. The multistep nature of cancer. Trends Genet. 3:1993;138.
23. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759.
24. Mertens F., Johansson B., Heim S., Kristoffersson U., Mitelman F. Karyotypic pattems in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia. 5:1991;214.
25. Miller J.B., Testa J.R., Lindgren V., Rowley J.D. The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis. Cancer. 55:1985;582.
26. Bos J.L., Vries M.V.-D., Van Der Eb A.J., Jansen J.W.G., Delwei R., Lowenberg B., Colly L.P. Mutations in N-RAS predominate in acute myeloid leukemia. Blood. 69:1987;1237.